CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2707
+0.0425 (18.60%)
Oct 19, 2026, 10:34 AM EST
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $397.8 million as of October 19, 2026. It is the 17,477th most valuable company in the world and the 3,071st biggest in the United States. Its market cap has increased by 18.36% in one year.
Market Cap
397.80M
Enterprise Value
408.71M
Revenue
n/a
Global Rank
Country Rank
#3,071 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 397.80M, an increase of 7,083.66%. That is a compound annual growth rate of 22.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 397.80M | 11.86% |
| Dec 31, 2025 | 355.63M | 164.14% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 562.96M |
| Northwest Biotherapeutics | 266.08M |
| Glorywin Entertainment Group | 234.77M |
| Vaxart | 110.10M |
| BetterLife Pharma | 98.39M |
| NDT Pharmaceuticals | 63.05M |
| Nuo Therapeutics | 62.96M |
| ProText Mobility | 52.75M |